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Observable essential fatty acid 
deficiency markers and Autism Spectrum Disorder
ABSTRACT
Autism Spectrum Disorder (ASD) has been associated with essential fatty acid (EFA) deficiencies, with some researchers 
theorising that dysregulation of phospholipid metabolism may form part of the biological basis for ASD. This pilot study 
compared observable signs of fatty acid status of 19 children with an ASD diagnosis to 23 of their typically developing 
siblings. A pregnancy, birth and breastfeeding history was also obtained from their parents, which included a measure 
of infant intake of fatty acid rich colostrum immediately post-partum. When considered within their family group, those 
infants not breastfed (with colostrum) within the first hour of life and who had a history of fatty acid deficiency symptoms 
were more likely to have an ASD diagnosis. Other variables such as formula use, duration of breastfeeding, gestational 
age and Apgar scores were not associated with group membership. The results of this study are consistent with previous 
research showing a relationship between fatty acid metabolism, breastfeeding and ASD such that early infant feeding 
practices and the influence this has on the fatty acid metabolism of the child may be a risk factor for ASD.
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INTRODUCTION
Autism Spectrum Disorder (ASD) represents a continuum 
of social and communication deficits generally diagnosed 
in childhood (Diagnostic and Statistical Manual of 
Mental Disorders, 5th edition, American Psychiatric 
Association). ASD prevalence has risen dramatically over 
recent decades with the latest estimates suggesting that 
as many as 1 in 88 children (1 in 54 males) have an ASD 
diagnosis: an increase of 23% in 2 years (Rice etal 2012). 
ASD represents a significant public health concern and 
definitive understandings as to its causation, prevention 
and treatment remain elusive.
There is an emerging acknowledgement that both the 
brain and whole body systems are implicated in ASD 
(Herbert 2010). In addition to evidence for genetic 
factors, there is growing evidence to suggest that immune 
dysregulation (Ashwood & Van de Water 2004) and 
inflammation (Vargas etal 2005), oxidative stress (Adams 
et al 2011), mitochondrial dysfunction (Weissman et al 
2008) and environmental toxicant exposures (Austin
2008; Palmer, Blanchard & Wood 2009; Roberts et al 
2007) may also be implicated (Rossignol & Frye 2012).
At a unique intersection of both genes and the 
environment are phospholipids: a class of lipids that are 
the major component of cell membranes (Horrobinl998). 
Brain phospholipids, rich in highly unsaturated fatty 
acids, are known to be essential for normal neurological 
function (El-Ansary, Ben Bacha & Kotb 2012). Although 
the enzymes involved in the breakdown of phospholipids 
are under genetic control, the essential fatty acids 
(EFAs) that determine the phospholipid structure must 
be provided exogenously through the diet. Proposed 
by Horrobin (1998) as a possible etiological basis of 
schizophrenia, dysregulated phospholipid metabolism 
has also been implicated in both ASD and Attention 
Deficit Hyperactivity Disorder (ADHD) (Bell et al 2004).
Fatty acid metabolism is influenced by sex hormones, 
with testosterone inhibiting and oestrogen stimulating 
the conversion of the essential fatty acids precursors
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(linoleic acid, LA and alpha-linolenic acid, ALA) into their 
metabolites (arachidonic acid, AA and docosahexaenoic 
acid, DHA) (Burdge 2004; Decsi & Kennedy 2011). Some 
researchers have theorised that this may, at least partly, 
explain the elevated rates of autism found in males 
compared to females (Schuchardt et al 2010).
A disruption to phospholipid metabolism is thought to 
reduce the availability of circulating fatty acids and thus 
result in fatty acid deficiencies (Horrobin 1998). Indeed, 
studies have found reduced fatty acid levels in the plasma 
of children with an ASD diagnosis (Antalis et al 2006; Bell 
et al 2004; Vancassel et al 2001). Although not all studies 
have found consistently reduced levels of fatty acids in 
children with an ASD diagnosis (Bu et al 2006), there 
has been a consistent finding of an undesirable ratio of 
omega-6 to omega-3 fatty acids (El-Ansary et al 2012; 
Bell et al 2010).
Another emerging body of research is revealing the 
impact of suboptimal breastfeeding practices on infant 
development and its association with ASD (Al-Farsi et al 
2012; Schultz et al 2006). Early weaning (Tanoue & Oda 
1989) and an entire absence of breastfeeding have been 
associated with an increased risk of an ASD diagnosis. 
One consequence of suboptimal breastfeeding practices 
is to decrease the likelihood of an infant receiving fatty 
acid rich colostrum, particularly when the initiation 
of breastfeeding is delayed (Al-Farsi et al 2012). In our 
previous review (Brown & Austin 2011) we theorised 
that colostral intake could reduce the risk of an ASD 
diagnosis by increasing the availability of EFAs to the 
infant at a critical developmental stage. Indeed, it may 
be more cogent to view colostrum not as a food source 
per se, but as a fundamental exogenous facilitator of a 
neonate’s metabolic development.
Although EFA status can be determined via biological 
testing of blood samples (El-Ansary, Bacha & Al-Ayahdi 
2011) and cheek cells (Kirby et al 2010), a non-invasive, 
observational test known as a Fatty Acid Deficiency 
score also has utility in the assessment of EFA status. In 
1930, Burr and Burr observed that rats on a fat-free diet 
developed excessive thirst and dandruff, reversible only 
with the addition of linoleic acid, a long chain EFA, in their 
diet. Observable symptoms of EFA deficiency in humans 
were first described by Colquhoun and Bunday (1981) 
who noticed that hyperactive children showed more signs 
of thirst than their undiagnosed peers. Later research by 
Stevens et al (1995) compared the incidence and severity 
of seven observable signs of EFA deficiency in boys with 
ADHD: excessive thirst, dry hair, dry skin, brittle nails, 
dandruff, frequent urination and keratosis pilaris (rough, 
dry bumpy skin on the upper arms and/or legs). Results 
showed that blood plasma concentrations of AA and 
DHA were significantly lower in those with the highest 
observable EFA deficiency score. These findings were 
replicated in ASD populations (Bell et al 2004; Vancassel
et al 2001) and Bell et al formalised these same seven 
symptoms in a questionnaire from which a Fatty Acid 
Deficiency (FAD) score could be derived.
The intent of this study was to ascertain whether FAD 
scores were elevated in a sample of children with ASD 
when compared to their normally developing siblings. 
Additionally, we aimed to determine if breastfeeding 
factors such as colostral intake and exclusivity of 
breastfeeding were associated with a diagnosis of ASD.
METHOD
Participants
Following receipt of ethics approval from Swinburne 
University Human Research Ethics Committee, 54 
families who were members of a database of supporters 
of autism research at Swinburne University in Melbourne, 
Australia, were contacted via email. Consent was given by 
19 families who volunteered to participate in this study. 
Telephone interviews were conducted with parents (18 
mothers, 1 father) in regard to their 42 children. Of these 
children, 19 had a diagnosis of ASD, whilst the remaining 
23 were typically developing. There was one set of 
dizygotic twins, with the male twin having a diagnosis of 
ASD and the female twin typically developing.
Survey items recorded the pregnancy histories of the 
mothers and the early feeding histories of the children. 
The feeding history of the children specifically asked 
whether the children had been breastfed in the first 
hour after birth and whether or not they had been 
exclusively breastfed as per World Health Organization 
(WHO) guidelines (no other liquids or nutrition for 
the first 6 months). Prenatal maternal fatty acid intake 
was measured by how many times per week fish was 
consumed during pregnancy.
The FAD measured seven observable signs of fatty acid 
deficiency: excessive thirst, frequent urination, dry 
skin, dry hair, soft or brittle nails, dandruff and rough, 
dry, bumpy skin. Parents were asked if their child had 
ever displayed any of these symptoms. Responses were 
scored as 0 (symptom absent) or 1 (symptom present) 
and summed to produce a total FAD score for each child, 
with higher scores indicating more observable signs of 
fatty acid deficiency.
Statistical analyses
Given the modest sample size, potentially relevant 
predictors of ASD were identified using chi-square tests 
for categorical variables and independent samples t-tests 
for interval variables. Following recommendations of 
Mickey and Greenland (1989), variables with p values 
<0.20 were subsequently included in a multivariate 
logistic regression model to assess their combined effect 
on ASD status. A cut-off value of p<0.20 is recommended 
for covariate selection as this conservative criterion tends
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to result in all potentially important covariates being 
accounted for, while excluding variables that are unlikely 
to make a meaningful contribution to the model. To 
account for children 'clustering' within families, logistic 
regression analysis was conducted using a generalised 
estimating equations approach (Zeger & Liang 1986).
Data were analysed using IBM SPSS Version 20 (IBM 
Corp NY). Nominal level of statistical significance was set 
at 0.05 for all tests, unless otherwise specified.
RESULTS
Demographic characteristics of study participants are 
shown in Tables 1 and 2. The majority of children (66.7%) 
were male and were born in hospital (90.5%). just over 
half (54.8%) were breastfed within an hour of birth and 
remained exclusively breastfed (57%). FAD scores for the 
study sample ranged between 0 and 4, with a median of 
0. Whilst eight mothers were aged in their 20s at the time 
of their children’s birth (19%), the majority of mothers 
(73.8%) were in their 30s, with only one mother in her 
40s (2.4%). Over half (54.8%) of all births involved birth 
interventions, including caesarean section (40.5%), 
ventouse (9.5%) and forceps (4.8%).
Independent samples t-tests comparing FAD scores, 
ultrasound exposure, gestation and birthweight for 
children with and without ASD diagnosis showed only 
FAD scores to differ significantly in regard to an ASD 
diagnosis (M=1.26, SD=1.32) and no ASD diagnosis 
(M=0.30, SD=0.47), groups t(40)=-3.23, p=0.002. 
Number of ultrasounds, gestation, birthweight and Apgar
score did not differ significantly between ASD diagnosis 
groups. Univariate chi-square tests showed that the 
associations between an ASD diagnosis and a child’s sex 
X2(l)=2.36, p=0.125, first hour breastfeeding x2(2)=3.92, 
p=0.141, exclusive breastfeeding x2(2)=0.85, p=0.653, 
place of birth x2 (1)=0.40, p=0.620 and maternal fish 
consumption x2(2)=2.13, p=0.343, were not significant. 
However, first hour breastfeeding and child’s sex met 
criteria for inclusion into a multivariate model (p<0.20).
Results were analysed using a multivariate logistic 
regression model with ASD diagnosis as outcome, FAD 
scores as main predictor and child’s sex and first hour 
feeding as covariates. Male gender, absence of first hour 
breastfeeding and higher FAD scores were significantly 
associated with higher odds of an ASD diagnosis (see 
Table 3).
DISCUSSION
This study found that FAD scores have a significant (and 
the most robust) relationship to a diagnosis of ASD, 
modest sample size notwithstanding. When considered 
within the family group, both first hour feeding and 
FAD scores were significantly associated with an ASD 
diagnosis. The findings of this study are consistent with 
previous research that has demonstrated an association 
between both fatty acid status (eg Bell et al 2010) and 
early infant feeding practices and ASD (Schultz 2006).
Our finding is also consistent with the hypothesis that 
fatty acid metabolism could be disrupted in individuals 
with ASD and also provides evidence to suggest that a







Sex Male 15 (78.9%) 13 (56.5%) 28 (66.6%)
Female 4(21.1%) 10 (43.5%) 14 (33.3%)
First hour breastfed Yes 9 (52.6%) 14 (60.9%) 23 (54.7%)
No 10 (47.4%) 6 (26.1%) 16 (38.0%)
Unknown 0 3 (13.0%) 3 (7.1%)
Place of birth Hospital 17 (89.5%) 21 (91.3%) 38 (90.4%)
Birthing centre 2 (10.5%) 2 (8.7%) 4 (9.5%)
Maternal fish consumption No fish 9 (47.4%) 15 (65.2%) 24 (57.1%)
during pregnancy Once/week 7 (36.8%) 7 (30.4%) 14 (33.3%)
Twice/week 3 (15.8%) 1 (4.3%) 4 (9.5%)
Exclusively breastfed Yes 11 (57.9%) 13 (56.5%) 24 (57.1%)
No 8 (42.1%) 9 (39.1%) 17 (40.4%)
Unknown 0 1 (4.3%) 1 (2.3%)
Formula fed Yes 8 (42.1%) 9 (39.1%) 17 (40.4%)
No 11 (57.9%) 13 (56.5%) 24 (57.1%)
Unknown 0 1 (4.3%) 1 (2.3%)
Mixed breastmilk and formula Yes 7 (36.8%) 8 (34.8%) 15 (35.7%)
No 12 (63.2%) 14 (60.9%) 26 (61.9%)
Unknown 0 1 (4.3%) 1 (2.3%)
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Table 2. Means (and standard deviations) for number of ultrasounds, gestation period, birthweight, Apgar and 





Ultrasounds 2.63 0.76 2.35 0.65
Gestation (weeks) 38.63 2.93 35.61 11.45
Birthweight (grams) 2734.52 1183.63 2044.56 1716.21
Apgar score2 5.37 3.98 3.78 4.17
FAD score 1.261 1.33 0.301 0.47
1 Indicates significant difference in group means at p<0.05
210-point Apgar score assessing prognosis and condition of newborn (Apgar 1953)
critical factor may not be exclusive breastfeeding in a 
general sense but, specifically, whether or not an infant 
has access to fatty acid-rich colostrum within the first 
hour (or hours) after birth. In this regard, it is essential 
to understand that the function of colostrum is not as 
a food for the neonate, but an important catalyst of the 
establishment of the biological mechanisms of the infant’s 
fatty acid metabolism. Consistent with this, a recent 
study by Al-Farsi et al (2012) found that both delayed 
colostrum intake and a reduced length of exclusive 
breastfeeding (up to 3 months versus up to 4 months) 
were significantly associated with an ASD diagnosis.
There are several limitations to this study. First, a small 
sample size limited the statistical power of the analyses, 
thus increasing the likelihood of type 2 error. Second, the 
telephone interviews necessitated self-reported birth and 
infant feeding histories. Although research has shown that 
the recall of birth characteristics reported by mothers is 
highly correlated with medical records (Sou et al 2006), 
it remains subject to recall error. Third, the breastfeeding 
history was recorded as a dichotomy (the presence 
or absence of exclusive breastfeeding). Many studies 
have shown a dose effect of breastfeeding (Al-Farsi et al 
2012; Schultz et al 2006; Tanoue & Oda 1989). In future
research it would be desirable to more accurately assess 
breastfeeding duration and to account for within-subject 
variability such as intermittent bouts of formula-feeding. 
It is also important to note that the FAD measure used in 
this study did not include a frequency, duration or severity 
measure, but rather recorded whether or not the child 
had ever displayed any of the FAD symptoms. Due to the 
robust finding that FAD scores were elevated in the ASD 
group, it would be important to modify the FAD measure 
to include frequency, duration and severity variables in 
future research and account for maternal fatty acid intake 
pre- and post-partum. Finally, a less homogeneous group 
than the group recruited for this study would be desirable. 
As previously outlined, in this group, most children 
were birthed in a hospital setting, many had medical 
interventions and most mothers were aged in their 30s at 
the time of their child’s birth. However, a broader cross- 
section of parental and birthing characteristics would allow 
other factors to be accounted for, such as home-birthing 
and the associated low levels of medical interventions 
that typically occur in such settings. Several risk factors 
associated with ASD are medicalised birth interventions 
such as caesarean section (Larsson et al 2005) and are 
the same risk factors associated with a reduced rate of 
breastfeeding (Donath & Amir 2008; Jordan et al 2005).
Table 3. Results of logistic regression analysis (with odds ratios) examining the association between ASD 
diagnosis and FAD score, with child’s sex and first hour breastfeeding as covariates.
Regression 
coefficient B (SE)
Odds ratio 95% Cl for odds 
ratio
p-value
Intercept 0.53 (0.72) 1.69 0.41
6.99
0.463
Sex -1.37 (0.90) 0.25 0.04
1.50
0.130
First hour breastfeeding -1.36 (0.64) 0.26 0.07
0.89
0.033*




* *  p<0.01.
24 B re a s tfe e d in g  R e v ie w  . VOLUME 22 • NUMBER 2 • JULY 2014
This study highlights the potential utility of observable 
fatty acid symptomatology in an ASD population in 
terms of both the quest to better understand the 
pathophysiology of the condition and also as a potential 
avenue for exploring supportive nutritional early 
intervention. This refers to both the examination of 
breastfeeding practices as a protective measure against 
ASD, as well as the possible clinical utility of fatty acid 
supplementation both pre- and postnatally. Clearly 
though, more research is needed to better understand 
the importance of the availability of fatty acids, primarily 
via colostrum, to the neonate and any potential role this 
may play in reducing an infant's risk of an ASD diagnosis.
This research was supported by the Swinburne Bio- 
Research Initiative (SABRI), Swinburne University 
Alumni and Development, and the Friends of SABRI.
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It started with six 
mums and a passion...
Read about the tears and triumphs of the Australian 
Breastfeeding Association (ABA, formerly the Nursing 
Mothers' Association) through the years in this new book 
to celebrate ABA's golden jubilee.
Full of amazing pictures, anecdotes and memories, 
Nursing Mums A h istory o f the Australian 
Breastfeeding Association 1964-2014 tells the story 
of how a grass-roots association founded by just six 
mothers grew to become a national organisation 
helping more than 80,000 mothers each year.
It's a story of courage, enterprise, dedication, 
passion and purpose as well as the difficulties and 
disagreements that all organisations must face.
Purchase your copy now at 
ABA's retailer Mothers Direct!
www. mothersd i rect.com .a u
Order online or in-store (see website for locations) or phone 1800 032 926
$ 4 4 .9 5
aba members
$ 4 9 .9 5
non-members
+ postage
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